Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Mar;61(1):30-37.
doi: 10.20471/acc.2022.61.01.04.

LONG-TERM SURVIVAL EFFECTS OF PREOPERATIVE BREAST MRI IN PATIENTS WITH BREAST-CONSERVING SURGERY

Ahmet Serkan Ilgun  1 , Dauren Sarsenov  2 , Gul Alco  3 , Alper Ozturk  4 , Filiz Agacayak  5 , Filiz Elbuken  6 , Zeynep Erdogan  7 , Kezban Nur Pilanci  8 , Cetin Ordu  9 , Fatma Aktepe  10 , Gursel Soybir  11 , Vahit Ozmen  12
Affiliations

LONG-TERM SURVIVAL EFFECTS OF PREOPERATIVE BREAST MRI IN PATIENTS WITH BREAST-CONSERVING SURGERY

Ahmet Serkan Ilgun et al. Acta Clin Croat. 2022 Mar.

Abstract

The benefit of breast magnetic resonance imaging (MRI) in breast-conserving surgery (BCS) is unclear. Our study compared breast cancer patients with and without preoperative breast MRI and their long-term oncologic outcomes are reported. A total of 1378 BCS cases with early breast cancer between 1996 and 2017 were reviewed. Patients with carcinoma in situ or neoadjuvant treatment or having breast MRI after tumor excision were excluded. Of 1378 patients, 270 (19.5%) had preoperative MRI. There were no significant differences regarding T and N stage and molecular subtypes between the groups. Surgical margins were significantly wider in the breast MRI group. Five-year overall survival (OS) was 96.9% in the MRI group and 94.3% in the control group, and this difference was not significant (p=0.11). Five-year local-regional recurrence-free survival (LRFS) was not significantly different either (98.8% and 96.5%, respectively, p=0.41). When analyses were repeated only for patients with hormone receptor-negative or triple-negative breast cancer, there was still no significant difference in OS, LRFS, or disease-free survival. In conclusion, MRI does not seem necessary in all patients undergoing BCS. New prospective randomized controlled trials are needed to determine appropriate use of preoperative MRI and its effects on oncologic outcomes in early breast cancer patients.

Keywords: Breast MRI; Breast cancer; Breast-conserving surgery; Local failure; Oncologic outcome; Overall survival.

PubMed Disclaimer

References

    1. Fisher B, Anderson S, Bryant J, Margolese RG, Deutsch M, Fisher ER, et al. Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer. N Engl J Med. 2002. October 17;347(16):1233–41. 10.1056/NEJMoa022152 - DOI - PubMed
    1. Veronesi U, Cascinelli N, Mariani L, Greco M, Saccozzi R, Luini A, et al. Twenty-year follow-up of a randomized study comparing breast-conserving surgery with radical mastectomy for early breast cancer. N Engl J Med. 2002. October 17;347(16):1227–32. 10.1056/NEJMoa020989 - DOI - PubMed
    1. Erić I, Petek Erić A, Koprivčić I, Babić M, Pačarić S, Trogrlić B. Independent factors for poor prognosis in young patients with stage I-III breast cancer. Acta Clin Croat. 2020. June;59(2):242–51. 10.20471/acc.2020.59.02.07 - DOI - PMC - PubMed
    1. Clough KB, Lewis JS, Couturaud B, Fitoussi A, Nos C, Falcou MC. Oncoplastic techniques allow extensive resections for breast-conserving therapy of breast carcinomas. Ann Surg. 2003. January;237(1):26–34. 10.1097/00000658-200301000-00005 - DOI - PMC - PubMed
    1. Mullenix PS, Cuadrado DG, Steele SR, Martin MJ, See CS, Beitler AL, et al. Secondary operations are frequently required to complete the surgical phase of therapy in the era of breast conservation and sentinel lymph node biopsy. Am J Surg. 2004. May;187(5):643–6. 10.1016/j.amjsurg.2004.01.003 - DOI - PubMed

LinkOut - more resources